Upload
Featured Recent Articles Topics Login Upload

Search Results for 'prevention adherence'

prevention adherence published presentations and documents on DocSlides.

Promoting Adherence and Retention in ARV-based Prevention
Promoting Adherence and Retention in ARV-based Prevention
by briana-ranney
Dr. Seema Sahay, Ph.D. Division of Social and Beh...
Adherence and Acceptability for PrEP formulations
Adherence and Acceptability for PrEP formulations
by olivia-moreira
Jessica Haberer, MD, MS. July . 24, . 2017. Confl...
Medication Adherence and Persistence
Medication Adherence and Persistence
by emery
PrEP Counseling Center. What is Medication Adheren...
Module 1: INTRODUCTION TO ORAL
Module 1: INTRODUCTION TO ORAL
by pamella-moone
PrEP. Version. : December . 2018. Outline of tra...
Conflict of Interest “No conflicts of interest to declare”
Conflict of Interest “No conflicts of interest to declare”
by karlyn-bohler
Lessons Learned from Tenofovir Vaginal Gel Studie...
Welcome HIV Prevention Tool Box
Welcome HIV Prevention Tool Box
by lindy-dunigan
Options . for preventing HIV. HIV Continuum of Ca...
How can programmes best support female sex workers to avoid HIV infection in Zimbabwe?
How can programmes best support female sex workers to avoid HIV infection in Zimbabwe?
by faustina-dinatale
A prevention cascade analysis. Elizabeth Fearon, ...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
Oral pre-exposure prophylaxis (PrEP) for populations at sub
Oral pre-exposure prophylaxis (PrEP) for populations at sub
by giovanna-bartolotta
Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP...
Million Hearts: The ABCS of Part C & D
Million Hearts: The ABCS of Part C & D
by test
Janet Wright, MD, FACC. Executive Director, Milli...
HIV Treatment-as-Prevention (TasP) for people who use illic
HIV Treatment-as-Prevention (TasP) for people who use illic
by tatyana-admore
The North American experience. M-J . MILLOY. Rese...
CPCRN Cervical Cancer Workgroup Presentation
CPCRN Cervical Cancer Workgroup Presentation
by tatyana-admore
Annual CPCRN Meeting, Chicago. Tuesday, May 24. t...
Characteristics and Oral
Characteristics and Oral
by lois-ondreau
PrEP. Adherence in the TDF2 Open-Label Extension...
MTN 034/IPM 045: REACH Reversing the Epidemic in Africa with Choices in HIV Prevention
MTN 034/IPM 045: REACH Reversing the Epidemic in Africa with Choices in HIV Prevention
by stefany-barnette
Lulu Nair (MBChB, MPH). MTN 034/IPM 045 Protocol ...
ADOLESCENT PrEP STUDIES
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
Acceptability of early initiation of
Acceptability of early initiation of
by alida-meadow
antiretrovirals. for treatment as prevention amo...
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by tawny-fly
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL
by alida-meadow
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...
Innovations in HIV Prevention Research
Innovations in HIV Prevention Research
by numeroenergy
:. Novel adherence and diagnostic technologies. Cr...
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW
by sophie
Version. : June 2019. Outline of training. Module ...